SARS-CoV-2 Spike Antikörper (C-Term)
Kurzübersicht für SARS-CoV-2 Spike Antikörper (C-Term) (ABIN7795015)
Target
Alle SARS-CoV-2 Spike Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Anti-SARS-CoV-2 Spike (CT)
-
Spezifität
- Rabbit Anti-SARS-CoV-2 recognizes an epitope near the C-terminus of SARS-CoV-2 Spike. This polyclonal antibody was purified using affinity chromatography. Background A coronavirus, SARS-CoV-2 was first identified in 2019 (COVID-19). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS-CoV-2 can be mediated by the binding of the viral spike protein, a glycosylated protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 μg/mL
-
Buffer
- This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02 % sodium azide as a preservative.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
-
-
- SARS-CoV-2 Spike
-
Substanzklasse
- Viral Protein
Target
-